Welcome to the all-new Vetlearn

  • Vetlearn is getting a new home. Starting this fall,
    Vetlearn becomes part of the NAVC VetFolio family.

    You'll have access to the entire Compendium and
    Veterinary Technician archives and get to explore
    even more ways to learn and earn CE by becoming
    a VetFolio subscriber. Subscriber benefits:
  • Over 500 hours of interactive CE Videos
  • An engaging new Community for tough cases
    and networking
  • Three years of NAVC Conference Proceedings
  • All-new articles (CE and other topics) for the entire
    healthcare team

To access Vetlearn, you must first sign in or register.


  • Registration for new subscribers will open in September 2014!
  • Watch for additional exciting news coming soon!
Become a Member

Veterinary Forum March 2007 (Vol 24, No 3)

FDA approves new labeling for Nuflor for bovine respiratory disease

    ROCKVILLE, Md.— The FDA approved an updated label for florfenicol (Nuflor, Schering-Plough Animal Health) to include the claim that the antibiotic kills bacteria associated with bovine respiratory disease (BRD).

    BRD is a major health problem in cattle and the most significant cause of economic loss for the cattle industry.

    The product can now claim that it has bactericidal activity against some strains of the two major bacteria that can cause BRD: Mannheimia haemolytica and Histophilus somni. Testing demonstrated that 99.9% of the bacteria were killed in 24 hours. After injection, florfenicol continues to kill the bacteria for a total of 68 hours. In addition, florfenicol inhibits one-third of Pasteurella multocida for 67 hours.

    A bacterial invasion of the lungs is a major component of BRD. The typical signs of BRD are associated with inflammation of the lungs and include breathlessness, fever, excess mucus, coughing and loss of appetite.

    NEXT: FDA approves new topical antiparasitic